4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 4,479$57,0180.04%
AFFINITY WEALTH MANAGEMENT LLC 11,471$146,0260.03%
Dynamic Technology Lab Private Ltd 26,330$3350.03%
Ghisallo Capital Management LLC 25,000$318,2500.03%
Sandia Investment Management LP 7,500$95,4750.03%
Verition Fund Management LLC 167,137$2,127,6540.02%
JANUS HENDERSON GROUP PLC 2,746,335$34,958,0450.02%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 348,700$4,438,9510.02%
Candriam S.C.A. 198,000$2,520,5400.02%
Point72 Asset Management, L.P. 453,376$5,771,4820.02%
PROFUND ADVISORS LLC 21,054$268,0170.02%
Trexquant Investment LP 44,443$565,7590.01%
Rafferty Asset Management, LLC 161,286$2,053,1710.01%
FIRST MANHATTAN CO. LLC. 160,392$2,041,7900.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 27,400$348,8020.01%
PANAGORA ASSET MANAGEMENT INC 75,688$963,5080.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 72,767$926,3240.01%
Point72 Middle East FZE 11,304$143,8940.01%
ExodusPoint Capital Management, LP 29,307$3730.00%
Vident Advisory, LLC 10,574$134,6070.00%
External links

This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.